Starting lithium prophylaxis early v. late in bipolar disorder

British Journal of Psychiatry

Volumn 205, Issue 3, 2014, Pages 214-220

  Kessing, Lars Vedel ^a   Vradi, Eleni ^b   Andersen, Per Kragh ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; PRESCRIPTION DRUG; TRANQUILIZER;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTACT EXAMINATION; DENMARK; EARLY INTERVENTION; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; MENTAL PATIENT; MIXED MANIA AND DEPRESSION; MONOTHERAPY; PATIENT IDENTIFICATION; PRESCRIPTION; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; REGISTER; THERAPY DELAY; TIME TO TREATMENT; TREATMENT RESPONSE; MIDDLE AGED; TIME; TREATMENT OUTCOME;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; DENMARK; FEMALE; HUMANS; LITHIUM; MALE; MIDDLE AGED; REGISTRIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84906973603     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.113.142802     Document Type: Article

References (41)

1. Kessing LV, Hansen MG, Andersen PK. Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. Br J Psychiatry 2004; 185: 372-7.
2. Tohen M, Hennen J, Zarate Jr CM, Baldessarini RJ, Strakowski SM, Stoll AL, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 2000; 157: 220-8.
3. Bourne C, Aydemir O, Balanza-Martinez V, Bora E, Brissos S, Cavanagh JT, et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand 2013; 128: 149-62.
4. Kessing LV, Nilsson FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord 2003; 73: 261-9.
5. Berk M, Berk L, Dodd S, Cotton S, Macneil C, Daglas R, et al. Stage managing bipolar disorder. Bipolar Disord 2013; 20 Jun (Epub ahead of print).
6. Goodwin GM, Geddes JR. Latest maintenance data on lithium in bipolar disorder. Eur Neuropsychopharmacol 2003; 13 (suppl 2): S51-5.
7. Coryell W. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice. Bipolar Disord 2009; 11 (suppl 2): 77-83.
8. Gray JD, McEwen BS. Lithium's role in neural plasticity and its implications for mood disorders. Acta Psychiatr Scand 2013; 128: 347-61.
9. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry 2013; 14: 154-219.
10. Kessing LV, Hansen HV, Christensen EM, Dam H, Gluud C, Wettersley J. Do young adults with bipolar disorder benefit from early intervention? J Affect Disord 2014; 152-154: 403-8.
11. Kleindienst N, Engel R, Greil W. Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders. Bipolar Disord 2005; 7: 404-17.
12. Kessing LV, Hellmund G, Andersen PK. Predictors of excellent response to lithium: results from a nationwide register-based study. Int Clin Psychopharmacol 2011; 26: 323-8.
13. Sachs GS, Printz DJ, Kahn OA, Carpenter D, Docherty JP. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med 2000; Spec No: 1-104.
14. Licht RW, Vestergaard P, Kessing LV, Larsen JK, Thomsen PH. Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand Suppl 2003; 419: 1-22.
15. Nolen WA, Kupka RW, Schulte PFJ, Knoppert-van der Klein EAM, Honig A, et al. Richtlijn Bipolaire Stoornissen (2nd edn) [The Dutch Guidelines for Bipolar Disorder]. UtrechtL De Tijdstrom uitgerverij BV, 2008.
16. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2013; 15: 1-44.
17. Goodwin GM. Evidence-based guidelines for treating bipolar disorder: revised second edition - recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009; 23: 346-88.
18. Munk-Jorgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull 1997; 44: 82-4.
19. Danish Health and Medicines Authority. Medicinal Product Statistics. Danish Health and Medicines Authority, 2002 (http://sundhedsstyrelsen.dk).
20. Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull 1999; 46: 354-7.
21. Andersen TF, Madsen M, Jorgensen J, Mellemkjaer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-8.
22. World Health Organization. Klassifikation af Sygdomme Systematisk del International Statistical [Classification of Diseases and Health Related Problems, Tenth Revision] (Danish Edition). Munksgaard, 1993.
23. WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs. WHO Collaborating Centre for Drug Statistics Methodology, 2003.
24. Kessing LV, Andersen PK, Mortensen PB. Predictors of recurrence in affective disorder. A case register study. J Affect Disord 1998; 49: 101-8.
25. Kessing LV, Sondergard L, Kvist K, Andersen PK. Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study. Bipolar Disord 2007; 9: 730-6.
26. Kessing LV. The effect of comorbid alcoholism on recurrence in affective disorder: a case register study. J Affect Disord 1999; 53: 49-55.
27. Farren CK, Hill KP, Weiss RD. Bipolar disorder and alcohol use disorder: a review. Curr Psychiatry Rep 2012; 14: 659-66.
28. Kulhara P, Basu D, Mattoo SK, Sharan P, Chopra R. Lithium prophylaxis of recurrent bipolar affective disorder: long-term outcome and its psychosocial correlates. J Affect Disord 1999; 54: 87-96.
29. Berghofer A, Alda M, Adli M, Baethge C, Bauer M, Bschor T, et al. Long-term effectiveness of lithium in bipolar disorder: a multicenter investigation of patients with typical and atypical features. J Clin Psychiatry 2008; 69: 1860-8.
30. Pfennig A, Schlattmann P, Alda M, Grof P, Glenn T, Müller-Oerlinghausen B, et al. Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders. Bipolar Disord 2010; 12: 390-6.
31. Maj M, Pirozzi R, Magliano L, Bartoli L. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. Am J Psychiatry 1998; 155: 30-5.
32. Calabrese JR, Rapport DJ, Youngstrom EA, Jackson K, Bilali S, Findling RL. New data on the use of lithium, divalproate, and lamotrigine in rapid cycling bipolar disorder. Eur Psychiatry 2005; 20: 92-5.
33. Fountoulakis KN, Kontis D, Gonda X, Yatham LN. A systematic review of the evidence on the treatment of rapid cycling bipolar disorder. Bipolar Disord 2013; 15: 115-37.
34. Kessing LV. Diagnostic stability in bipolar disorder in clinical practise as according to ICD-10. J Affect Disord 2005; 85: 293-99.
35. Perugi G, Micheli C, Akiskal HS, Madaro D, Socci C, Quilici C, et al. Polarity of the first episode, clinical characteristics, and course of manic depressive illness: a systematic retrospective investigation of 320 bipolar I patients. Compr Psychiatry 2000; 41: 13-8.
36. Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010; 375: 385-95.
37. Kessing LV, Hellmund G, Geddes JR, Goodwin GM, Andersen PK. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry 2011; 199: 57-63.
38. Kessing LV, Hellmund G, Andersen PK. An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder. J Psychopharmacol 2012; 26: 644-52.
39. Malhi GS. The king is dead, long live the king! The restoration of BALANCE. Bipolar Disord 2010; 12: 681-4.
40. Ghaemi SN. From BALANCE to DSM-5: taking lithium seriously. Bipolar Disord 2010; 12: 673-7.
41. Pfennig A, Bschor T, Falkai P, Bauer M. The diagnosis and treatment of bipolar disorder: recommendations from the current s3 guideline. Dtsch Arztebl Int 2013; 110: 92-100.